Other languages ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
5.05 ^USD	+2.64%		-6.83%	+11.73%

05-09	Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M	MT
05-09	Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09
ProPhase Labs, Inc. Unveils Project ZenQ-AI	04-16
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-15
Prophase Labs, Inc. Announces Important Developments in the Company?s Efforts to Commercialize Its Novel Be-Smart Esophageal Cancer Diagnostic Test	02-20
ProPhase Labs, Inc. Announces Preliminary Positive Results for Dietary Supplement Equivir	02-14
ProPhase Labs Names Jed Latkin as Chief Operating Officer	01-04
ProPhase Labs, Inc. Appoints Jed Latkin as COO	01-04
ProPhase Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-09
ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	10/08/23
Navidea Biopharmaceuticals Confirms Rejection of ProPhase Labs' Proposal to Buy Some of Its Assets	30/06/23
ProPhase Labs, Inc. cancelled the acquisition of Certain Assets from Navidea Biopharmaceuticals, Inc. for $7 million.	28/06/23
ProPhase Labs, Inc Provides an Update Regarding Its Progress and Development Strategy for Linebacker-1	01/06/23
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23
Prophase Labs, Inc. Provides an Update Regarding its Progress and Development Strategy for Linebacker-1	03/05/23
ProPhase Labs Board Authorizes Up to $6 Million Share Repurchase Program	15/03/23
ProPhase Labs, Inc. announces an Equity Buyback for $6 million worth of its shares.	15/03/23
ProPhase Labs Unit Introduces DNA Test Direct to Consumer at Lower Cost	07/03/23
ProPhase Plans Clinical Study of Over-the-Counter Equivir for Upper Respiratory Tract Infections	22/02/23
ProPhase Labs Plans Expansion for Contract Manufacturing Subsidiary	15/02/23
ProPhase Labs, Inc. Provides Update on Linebacker-1 Cancer Co-Therapy Program and Outlines Development Strategy	06/02/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ProPhase Labs, Inc.

Equities

PRPH

US74345W1080

Other languages

Filters